Ductal Lavage Cytology
Also known as: Breast Ductal Lavage Cytology, FirstCyte™ Breast Test
Use
Determine and/or differentiation of normal versus premalignant versus malignant cells
Special Instructions
Not provided.
Limitations
The results of the ductal lavage cytology test should not be used as definitive evidence for the presence or absence of breast carcinoma. This test is intended to be used in conjunction with other breast cancer detection methodologies, such as mammography and physical examination, for a more comprehensive evaluation.
Methodology
Other
Biomarkers
LOINC Codes
- 22633-2 - Path report.site of origin Spec
- 52797-8 - Dx ICD code
- 47526-9 - Cytology Spec Doc Cyto
- 22638-1 - Path report.comments Imp Spec
- 22636-5 - Path report.relevant Hx Spec
- 22639-9 - Path report.supplemental reports Spec
- 19139-5 - Pathologist name
- 22634-0 - Path report.gross Spec
- 22635-7 - Path report.microscopic Spec Other Stn
Result Turnaround Time
1 day
Related Documents
For more information, please review the documents below
Specimen
Body Fluid
Volume
Entire CytoLyt® tube
Minimum Volume
Entire CytoLyt® tube
Container
CytoLyt® solution (30 mL tube)
Collection Instructions
Follow instructions in the FirstCyte™ Breast Test package insert. Specific procedures include using a FirstCyte™ Aspirator and MicroCatheter, administering lidocaine, infusing electrolyte solution, and collecting ductal effluent.
Patient Preparation
Refer to FirstCyte™ instructions for use.
Storage Instructions
Store in a cool dry place.
Causes for Rejection
Improper fixation; improper labeling; specimen submitted in vial that expired according to manufacturer's label
Other tests from different labs that may be relevant